Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Thrombosis and Haemostasis|June 12, 2025
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation: A Real-World Propensity Score-Matched StudyLaurent Fauchier, Lisa Lochon, Thibault Lenormand, et al.The American Journal of Medicine|March 11, 2026
Reassessing the Association Between Celiac Disease and Cardiovascular Events: A Large Propensity-Matched Analysis from a Global Federated Research NetworkLaurent Fauchier, Thibault Lenormand, Lisa Lochon, et al.Heart (British Cardiac Society)|August 19, 2025
Incident cardiovascular events in women with left-sided versus right-sided breast cancer: a propensity score-matched studyLaurent Fauchier, Lisa Lochon, Thibault Lenormand, et al.JACC. Advances|April 2, 2026
SGLT2 Inhibitors and Mortality in Endometriosis With Type 2 Diabetes: A Propensity-Matched AnalysisBenjamin Marchandot, Olivier Morel, Mickael Guglieri, et al.Journal of Clinical Medicine|February 26, 2025
Outcomes in Atrial Fibrillation Patients with Different Clinical Phenotypes: Insights from the French PopulationAmeenathul M Fawzy, Arnaud Bisson, Lisa Lochon, et al.Journal of Clinical Medicine|October 16, 2025
Association of SGLT2 Inhibitors with Mortality and Bioprosthesis Valve Failure After TAVR: A Propensity-Matched Cohort StudyOlivier Morel, Amandine Granier, Lisa Lochon, et al.Stroke|June 5, 2025
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Nontraumatic Intracerebral Hemorrhage in Patients With Type 2 DiabetesMarco Pasi, Arnaud Bretonnière, Lisa Lochon, et al.Circulation. Arrhythmia and Electrophysiology|December 25, 2025
Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data AnalysisSandrine Venier, Pascal Defaye, Lisa Lochon, et al.European Journal of Heart Failure|February 27, 2026
Association of SGLT2 inhibitors and new-onset dementia in non-diabetic patients with heart failureAbdelhakim Hacil, Matthieu Piccoli, Yara Antakly-Hanon, et al.Diabetes, Obesity & Metabolism|February 10, 2025
GLP-1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesityTommaso Bucci, Uazman Alam, Grégoire Fauchier, et al.Pageof 2